0001437749-16-033646.txt : 20160712 0001437749-16-033646.hdr.sgml : 20160712 20160610105301 ACCESSION NUMBER: 0001437749-16-033646 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20160610 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VIVEVE MEDICAL, INC. CENTRAL INDEX KEY: 0000879682 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 043153858 STATE OF INCORPORATION: B0 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: 150 COMMERCIAL STREET CITY: SUNNYVALE STATE: CA ZIP: 94086 BUSINESS PHONE: 4085301900 MAIL ADDRESS: STREET 1: 150 COMMERCIAL STREET CITY: SUNNYVALE STATE: CA ZIP: 94086 FORMER COMPANY: FORMER CONFORMED NAME: PLC SYSTEMS INC DATE OF NAME CHANGE: 19930328 CORRESP 1 filename1.htm vive20160610_corresp.htm

Viveve Medical, Inc.

150 Commercial St.

Sunnyvale, CA 94086

 

June 10, 2016

 

VIA EDGAR

 

Amanda Ravitz

Assistant Director

United States Securities and Exchange Commission

Division of Corporate Finance/Mail Stop 303

100 F Street, N.E.

Washington, D.C. 20549

 

Re:          Viveve Medical, Inc.

Registration Statement on Form S-1

Filed on April 19, 2016 and amended on May 19, 2016,

May 24, 2016 and June 9, 2016

File No. 333-210816

 

Dear Ms. Ravitz:

 

Viveve Medical, Inc. (the “Company”) hereby requests that the Securities and Exchange Commission (the “Commission”) take appropriate action to make the above-captioned registration statement (the “Filing”) be ordered effective at 4:15 p.m., Eastern time, on June 13, 2016 or as soon as practicable thereafter.

 

In requesting acceleration, the Company acknowledges that:

 

(1)     should the Commission or the staff, acting pursuant to delegated authority, declare the Filing effective, it does not foreclose the Commission from taking any action with respect to the Filing;

 

(2)     the action of the Commission or the staff, acting pursuant to delegated authority in declaring the Filing effective does not relieve the Company from its full responsibility for the adequacy and accuracy of the disclosure in the Filing; and

 

(3)     the Company may not assert comments of the Commission and the staff and the declaration of effectiveness of the Filing as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.

 

 

 

Very truly yours,

 

     
  VIVEVE MEDICAL, INC.  

 

 

 

 

 

 

 

 

 

By:

/s/ Patricia Scheller

 

 

 

Patricia Scheller, Chief Executive Officer